Skip to main content

Advertisement

SpringerLink
Log in

The efficacy of Xialine® in patients with Sjögren’s syndrome: a single-blind, cross-over study

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Sjögren syndrome (SS) is a chronic inflammatory autoimmune disease of unknown cause whose main characteristic is severe dryness of the eyes and the mouth. The decreased functional capacity of the lacrimal and salivary glands which is the result of the inflammatory process and lymphocytic infiltration observed in SS is accountable for this complication. Twenty-nine patients with SS whose ages were ranging between 24–77, who were under treatment in Ege University Faculty of Medicine Department of Rheumatology, participated in the study, and their informed consents were obtained upon enrollment. Each patient recorded their subjective complaints on a separate questionnaire. The baseline and subsequent evaluation of the subjective findings on predetermined times (1 h after application of the material, at the end of the 1st, 7th, and 14th days) were also recorded on separate questionnaire sheets. Throughout the 14-day treatment period, no statistically significant differences were noted between the Xialine® and placebo groups with regard to burning tongue, diminished taste, and waking up at night to sip water (p = 0.925, 0.527, and 0.066, respectively). However, patients’ satisfaction with placebo decreased by 25.63% at the end of the test period, whereas it increased by 16.37% after Xialine® administration. Overall, the patients preferred Xialine® at the end of the study (p = 0.011). The main motive to administer saliva substitute is to improve lubrication and hydration of oral tissues. The results of this study indicated that Xialine® is helpful in the management of xerostomia-related symptoms of SS patients. However, further investigations in larger scale group of patients are recommended to provide the effects of these agents on various complaints of xerostomia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Akhtar-Danesh N (2001) A review for statistical methods for analysing pain measurements. Eur J Pain 5:457–463

    Article  PubMed  Google Scholar 

  2. Alves M, Motta CF, Messina W (2004) Saliva substitute in xerostomic patients with primary Sjögren’s syndrome: A single-blind trial. Quintessence Int 35:392–396

    PubMed  Google Scholar 

  3. Amerongen AVN, Veerman ECI (2003) Current therapies for xerostomia and salivary with cancer therapies. Support Care Cancer 11:226–231

    Google Scholar 

  4. Bainbridge D, Martin JE, Cheng DC (2006) Patient-controlled versus nurse-controlled analgesia after cardiac surgery—a meta-analysis. Can J Anaesth 53:492–499

    PubMed  Google Scholar 

  5. Bergdahl M (2000) Salivary flow and oral complaints in adult dental patients. Community Dent Oral Epidemiol 28:59–66

    Article  PubMed  Google Scholar 

  6. Caraceni A, Brunelli C, Martini C, Zecca E, De Conno F (2005) Cancer pain assessment in clinical trials. A review of the literature (1999–2002). J Pain Symptom Manage 29:507–519

    Article  PubMed  Google Scholar 

  7. Chisholm DM, Mason D (1968) Labial salivary gland biopsy in Sjögren’s disease. J Clin Path 21:656–660

    Article  PubMed  Google Scholar 

  8. Christersson CE, Lindh L, Arnebrandt T (2000) Film forming properties and viscosities of saliva substitutes and human whole saliva. Eur J Oral Sci 108:418–425

    Article  PubMed  Google Scholar 

  9. Çankaya H, Kabasakal Y (2001) Comparison of subjective and objective oral findings in patients with Sjögren’s Syndrome. Balk J Stom 5:115–117

    Google Scholar 

  10. de Hertogh WJ, Vaes PH, Vijverman V, de Cordt A, Duquet W (2006) The clinical examination of neck pain patients: The validity of a group of tests. Man Ther (in press), PMID Number 16769236

  11. Fife RS, Chase WF, Dore RK, Wiesenhutter CR, Lockhart PB, Tindall E, Suen JY (2002) Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome. Arch Intern Med 162:1293–1300

    Article  PubMed  Google Scholar 

  12. Fox PC (2004) Salivary enhancement therapies. Caries Res 38:241–246

    Article  PubMed  Google Scholar 

  13. Freeman K, Smyth C, Dallam L, Jackson B (2001) Pain measurement scales: a comparison of the visual analogue and faces rating scales in measuring pressure ulcer pain. J Wound Ostomy Continence Nurs 28:290–296

    PubMed  Google Scholar 

  14. Gould D, Kelly D, Goldstone L, Gammon J (2001) Examining the validity of pressure ulcer risk assessment scales: developing and using illustrated patient simulations to collect the data. J Clin Nurs 10:97–706

    Article  Google Scholar 

  15. Guest S, Essick G, Young M, Lee A, Phillips N, McGlone F (2006) Oral hydration, parotid salivation and the perceived pleasantness of small water volumes. Physiol Behav 89:724–734

    Article  PubMed  Google Scholar 

  16. http://www.answers.com/topic/xanthan-gum, 2007

  17. http://www.lsbu.ac.uk/water/hyxan.html, 2007

  18. Jamison RN, Raymond SA, Slawsby EA, McHugo GJ, Baird JC (2006) Pain assessment in patients with low back pain: Comparison of weekly recall and momentary electronic data. J Pain 7:192–199

    Article  PubMed  Google Scholar 

  19. Jellema AP, Langendijk H, Bergenhenegouwen L, van der Reijden TJK, Leemans R, Smeele L, Slotman BJ (2001) The efficiacy of Xialine in patients with xerostomia resulting from radiotherapy for head and neck cancer: a pilot study. Radiother Oncol 59:157–160

    Article  PubMed  Google Scholar 

  20. Jensen SB, Pedersen AM, Reibel J, Nauntofte B (2003) Xerostomia and hypofunction of the salivary glands in cancer theraphy. Support Care Cancer 11:207–225

    PubMed  Google Scholar 

  21. Jorkjend L, Johansson A, Johansson A-K, Bergenholtz A (2004) Resting and stimulated whole salivary flow rates in Sjögren’s syndrome patients over time: a diagnostic aid for subsidized dental care? Acta Odontol Scand 62:264–268

    Article  PubMed  Google Scholar 

  22. Kahn ST, Johnstone PA (2005) Management of xerostomia related to radiotherapy for head and neck cancer. Oncology (Williston Park) 19:1827–1839

    Google Scholar 

  23. Khurshudian AV (2003) A pilot study to test the efficacy of oral administration of interferon lozenges to patients with Sjögren’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 95:38–44

    Google Scholar 

  24. Levine MJ (1993) Development of artificial salivas. Crit Rev Oral Biol Med 4:279–286

    PubMed  Google Scholar 

  25. Mignogna MD, Fedele S, Russo LL, Muzio L, Wolf A (2005) Sjögren’s syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia. J Oral Pathol Med 34:1–6

    Article  PubMed  Google Scholar 

  26. Meyer-Lueckel H, Tschoppe P, Kielbassa AM (2006) Effect of various Ca+2/PO4 -3concentrations of linseed-based saliva substitutes on enamel in vitro. J Oral Rehab 33:760–766

    Article  Google Scholar 

  27. Narhi TM, Meurman JK, Ainamo A (1999) Xerostomia and hyposalivation. Causes, consequences and treatment in the elderly. Drugs Aging 15:103–116

    Article  PubMed  Google Scholar 

  28. Navazesh M, Christensen C, Brightman V (1992) Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 71:1363–1369

    PubMed  Google Scholar 

  29. Park MS, Chung JW, Kim YK, Chung SC, Kho HS (2007) Viscosity and wettability of animal mucin solutions and human saliva. Oral Diseases 13:181–186

    Article  PubMed  Google Scholar 

  30. Porter SR, Scully C, Hegarty AM (2004) An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 97:28–46

    Article  Google Scholar 

  31. Preetha A, Banerjee R (2005) Comparison of artificial saliva substitutes. Trends Biomater Artif Organs 18:178–186

    Google Scholar 

  32. Puy LC (2006) The role of saliva in maintaining oral health and as an aid to diagnosis. Med Oral Patol Cir Bucal 11:449–455

    Google Scholar 

  33. Reijden WA, Vissink A, Veerman EC, Amerongen AVN (1999) Treatment of oral dryness related complaints (xerostomia) in Sjögren’s syndrome. Ann Rheum Dis 58:465–473

    Article  PubMed  Google Scholar 

  34. Samarawickrama DYD (2002) Saliva substitutes: how effective and safe are they? Guest Editorial. Oral Dis 8:177–179

    Article  PubMed  Google Scholar 

  35. Saunders BD, Trapp RG (1994) Basic and clinical biostatistics, 2nd edn. Prentice-Hall, International Inc, pp 138–139

  36. Shahdad SA (2005) A double-blind, cross-over study of Biotene Oralbalance and Bioxtra systems as salivary substitutes in patients with post-radiotheraphy xerostomia. Eur J Cancer Care 14:319–326

    Article  Google Scholar 

  37. Ship JA (2002) Diagnosing, managing, and preventing salivary gland disorders. Oral Dis 8:77–89

    Article  PubMed  Google Scholar 

  38. Smith G, Smith AJ, Shaw L, Shaw MJ (2001) Artificial saliva substitutes and mineral dissolution. J Oral Rehab 28:728–731

    Article  Google Scholar 

  39. Sokka T (2005) Assessment of pain in rheumatic diseases. Clin Exp Rheumatol 23(5 Suppl 39):77–84

    Google Scholar 

  40. Wu AJ (2003) The oral component of Sjogren's syndrome: pass the scalpel and check the water. Curr Rheumatol Rep 5:304–310

    Article  PubMed  Google Scholar 

  41. Zanoli G (2005) Outcome assessment in lumbar spine surgery. Acta Orthop Suppl 76:5–47

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Dentistry, Department of Oral Diagnosis and Radiology, Ege University, Bornova, İzmir, 35100, Turkey

    Esin Alpöz, Pelin Güneri & Hülya Çankaya

  2. Faculty of Medicine, Department of Rheumotology, Ege University, Bornova, İzmir, 35100, Turkey

    Gonca Önder & Yasemin Kabasakal

  3. Faculty of Computer Engineering, Ege University, Bornova, İzmir, 35100, Turkey

    Timur Köse

Authors
  1. Esin Alpöz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pelin Güneri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gonca Önder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hülya Çankaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yasemin Kabasakal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Timur Köse
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Esin Alpöz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alpöz, E., Güneri, P., Önder, G. et al. The efficacy of Xialine® in patients with Sjögren’s syndrome: a single-blind, cross-over study. Clin Oral Invest 12, 165–172 (2008). https://doi.org/10.1007/s00784-007-0159-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-007-0159-3

Keywords

Search

Navigation